Committee (IACUC) in the local interpretation and application of the law. is responsible for establishing guidelines and policies regulating animal use. reviewing protocols with surgical components. anesthesia/analgesia selection, and post-operative care and analgesia.
AYou will receive treatment with OPDIVO in a hospital or clinic, under the supervision of an experienced doctor. OPDIVO will be given to you as an infusion (a drip) into a vein (intravenously) over a period of 60 minutes, every 2 weeks.
Trade name : OpdivoÂ®. Nivolumab is the generic name for the trade drug name OpdivoÂ®. In some cases, health care professionals may use the generic name nivolumab when referring to the trade drug name OpdivoÂ®. Drug type: Nivolumab is a targeted therapy. It is a human programmed death receptor-1 (PD-1) blocking antibody.